How long can a person with cardia cancer live? Why is the survival time short after cardia cancer surgery?

Cardiac cancer is a relatively serious disease that causes great harm to the human body. It is not easy to treat, so early diagnosis is very critical. So how long can you live with cardiac cancer? This is a question that patients are very worried about. Let's take a look. Cardiac cancer is an adenocarcinoma that occurs in the cardia of the stomach, which is about 2 cm below the esophageal-gastric junction. It is a special type of gastric cancer and should be distinguished from lower esophageal cancer. However, it is different from gastric cancer in other parts of the body. It has its own anatomical and histological characteristics and clinical manifestations, unique diagnostic and treatment methods, and poor surgical treatment effects.

Cardiac cancer has a short survival time and poor prognosis after surgery, which may be related to the following factors:

1) The site of disease occurrence is relatively hidden and by the time of diagnosis, it is usually in the middle or late stages.

2) Its histological type is mostly adenocarcinoma. Some studies have confirmed that adenocarcinoma is more invasive than squamous cell carcinoma and metastasizes earlier. Previous studies on the preoperative treatment of esophageal cancer and cardiac cancer mainly used chemotherapy + radiotherapy + surgery or chemotherapy combined with multiple anticancer drugs + surgery.

Although the long-term survival rate of postoperative patients has improved, it still has some shortcomings as a preoperative treatment option:

1) The preoperative treatment period is too long, generally about 1.5 to 2 months, which will cause the patient to lose the best time for surgery.

2) Multiple anticancer drugs are used in combination, and the dosage is mostly conventional. Therefore, some patients experience strong toxic and side effects and are forced to stop taking the drugs.

3) Some patients may develop liver or abdominal lymph node metastasis during chemotherapy, or lose the opportunity for surgery due to liver or kidney dysfunction.

4) The main method of drug administration is intravenous drip or arterial infusion, which is highly technical and must be performed under the close cooperation of doctors and nurses.

5) The cost of treatment has been greatly increased, which has increased the economic burden on patients. In view of the above reasons, FPLC is used as a preoperative medication, which can not only avoid the various unfavorable factors of the above-mentioned preoperative treatment plans, but also contains ginseng and bean lecithin, which can enhance the body's immune function. According to pathological observations after medication, cancer cells undergo obvious degeneration and necrosis, and the tumor shrinks. Therefore, it shows the reliability of histological changes after preoperative medication, and also confirms the feasibility of implementing FPLC treatment.

Daily care of patients is also very important. Nurses should talk and communicate with family members in a timely manner, remind them to be fully prepared mentally and maintain a good mood, show sympathy and understanding for some of the patients' out-of-control behaviors, and guide family members to do some life care. Nurses should provide convenience as much as possible, actively cooperate, and resolve reasonable requests raised by patients.